Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes

Lignende værker

• The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
  af: He, Suqin, et al.
  Udgivet: (2014)
• Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression
  af: HE, SUQIN, et al.
  Udgivet: (2012)
• Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
  af: Proia, David A., et al.
  Udgivet: (2012)
• The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer
  af: Smith, Donald L., et al.
  Udgivet: (2014)
• The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
  af: Gomez-Casal, Roberto, et al.
  Udgivet: (2015)